Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-08-25 Sale | 2021-08-27 8:02 pm | Prelude Therapeutics Inc | PRLD | Piper Brian Chief Financial Officer | 8,333 | $33.34 | $277,827 | 264,329 (Direct) | View |
| 2021-05-25 Sale | 2021-05-27 5:03 pm | Prelude Therapeutics Inc | PRLD | Piper Brian Chief Financial Officer | 8,333 | $34.27 | $285,537 | 272,662 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-08-25 Exercise | 2021-08-27 8:02 pm | N/A N/A | Prelude Therapeutics Inc | PRLD | Piper Brian Chief Financial Officer | 8,333 | $1.89 | 264,329 (Direct) | View |
| 2021-08-25 Exercise | 2021-08-27 8:02 pm | N/A 2029-08-06 | Prelude Therapeutics Inc | PRLD | Piper Brian Chief Financial Officer | 8,333 | $0 | 264,329 (Direct) | View |
| 2021-07-20 Option Award | 2021-07-22 6:09 pm | N/A 2031-07-19 | Prelude Therapeutics Inc | PRLD | Piper Brian Chief Financial Officer | 115,650 | $0 | 115,650 (Direct) | View |
| 2021-05-25 Exercise | 2021-05-27 5:03 pm | N/A N/A | Prelude Therapeutics Inc | PRLD | Piper Brian Chief Financial Officer | 8,333 | $1.89 | 272,662 (Direct) | View |
| 2021-05-25 Exercise | 2021-05-27 5:03 pm | N/A 2029-08-06 | Prelude Therapeutics Inc | PRLD | Piper Brian Chief Financial Officer | 8,333 | $0 | 272,662 (Direct) | View |
Ownership | 2020-09-24 7:27 pm | N/A 2029-08-06 | Prelude Therapeutics Inc | PRLD | Piper Brian Chief Financial Officer | 0 | $0 | 462,559 (Direct) | View |